Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseWoundSv129Ev wild-type and ChemR23-deficient mice for excisional wounding; C57Bl6/J for intravital imagingTopical into the wound cavity; intradermal for the burn imaging model100 pg per wound in 40 microlitres of 30% Pluronic F-127 ge…Immediately after wounding
Model: Four full-thickness excisional wounds made with a 4 mm biopsy punch on shaved dorsal skin, removing epidermis, dermis and panniculus carnosus; small cutaneous burn wounds used for intravital imaging
C15 accelerated wound closure (36% versus 70% of starting size at day 4) and earlier scab loss, cut neutrophil numbers by 68% and neutrophil adhesion by 74% at 2 h, and reduced collagen fibre alignment from 0.90 to 0.71 versus 0.57 in unwounded skin, indicating less scarring.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.